Zentynel emerges as a convergent evolution between a group related to Fundación Ciencia y Vida (FCV) (Pablo Valenzuela, Bernardita Méndez and Cristián Hernández), along with Venturance Alternative Assets. Following a review of different industries, they identified that biotechnological entrepreneurs needed an investor specialized, along with the opportunity to provide capital and experience and thus accelerate the development and growth of this type of initiatives. We want to help close the existing investment gap with Biotechnology-based projects in Latin America, from research and local development to execution and global marketing.